Study of the Effects of Itraconazole and Carbamazepine on LY3410738 in Healthy Participants

NCT05205447 ↗

Phase 1 Terminated 27 enrolled Eli Lilly and Company Loxo Oncology, Inc. · collab

Non-randomizedSequentialOpen-labelBasic science

Summary

The main purpose of this study is to learn about how itraconazole and carbamazepine affect the levels of LY3410738 in the blood stream of healthy participants. Participation could last up to 75 days.

Timeline

Start: 2022-01-05
Primary completion: 2022-04-12
Completion: 2022-04-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CRELOSIDENIB	Small molecule	—	Oral
Subject	Carbamazepine	Small molecule	—	Oral
Subject	Itraconazole	Small molecule	—	Oral

Indications

No indication recorded.